Anondita Medicare Limited's board approved a ₹29.13 Crore preferential issue of 2,85,000 convertible warrants to promoter Mr. Anupam Ghosh. The board also approved material related party transactions, an object clause alteration, and increased remuneration for top management. These strategic moves aim to strengthen capital and align operations for FY 2026-27.
Anondita Medicare Limited's board approved the issuance of warrants to promoters, material related party transactions for FY 2026-27, and an increase in remuneration for its Managing and Whole-Time Directors. The board also called an EGM for shareholder approval of these matters and proposed an alteration to the company's Memorandum of Association.
Anondita Medicare Limited has scheduled a Board Meeting on April 30, 2026, to consider a proposal for fund raising. The trading window for designated persons has been closed from April 1, 2026, until June 2, 2026.
